PuSH - Publikationsserver des Helmholtz Zentrums München: Lipid nanoparticles and nanoemulsions exploited in the diagnosis and treatment of infectious diseases.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Tiwari, A.* ; Gulbake, A.S.* ; Kumar, P.

Lipid nanoparticles and nanoemulsions exploited in the diagnosis and treatment of infectious diseases.

In: Nanotheranostics for Treatment and Diagnosis of Infectious Diseases. 2022. 229-273 (Nanotheranostics for Treatment and Diagnosis of Infectious Diseases)

DOI

Abstract
Metriken
Zusatzinfos

In the 20th century, the primary option for the treatment of infectious diseases was based on using conventional antibiotics, antivirals, antifungals, antiprotozoals, and anthelminthics drugs. However, these therapies lose their therapeutic value with time due to the development of drug resistance in microorganisms. The concept of immunization is also a well-developed strategy to prevent infectious diseases in humans and other animals, which harness the endogenous disease-fighting immune mechanism. Advancement in nanotechnology transformed the conventional approaches for disease treatment and diagnosis. The nanocarriers are effective in inducing the naïve immune activity against the pathogens/immune diseases and are capable to improve the therapeutic value significantly. Lipid nanoparticles and nanoemulsions having a composition similar to the intrinsic cell membrane are novel vehicles for the delivery of therapeutic compounds in a controlled and temporal manner. Thus, they can improve the medicinal value of therapeutic compounds by improving the specificity up to molecular level target, avoidance of off-target delivery with minimum or no adverse events. The ease of development approaches makes them suitable as a potential tool for disease diagnosis and the delivery of traditional drugs, proteins as well as nucleic acid-based therapeutics. The manipulation of these lipid-based nanocarriers could further help in avoidance of foreign body immune reactions and reticuloendothelial escape (RES) uptake, in addition to high loading and targeting efficiency, enhanced permeation, and retention (EPR), intracellular delivery and lesser toxicity. It enables the lipid nano carriers as the potential tool to combat the infectious diseases. The current chapter is focused on the development of these lipid-based nanocarriers, their diagnostic and therapeutic applications and outlines the possible strategies to improve the scope of lipid-based carriers in infectious diseases.

Altmetric